85 related articles for article (PubMed ID: 29555676)
1. Pillars Article: Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA.
Bauer S; Groh V; Wu J; Steinle A; Phillips JH; Lanier LL; Spies T
J Immunol; 2018 Apr; 200(7):2231-2233. PubMed ID: 29555676
[No Abstract] [Full Text] [Related]
2. An NKG2D-mediated human lymphoid stress surveillance response with high interindividual variation.
Shafi S; Vantourout P; Wallace G; Antoun A; Vaughan R; Stanford M; Hayday A
Sci Transl Med; 2011 Dec; 3(113):113ra124. PubMed ID: 22133594
[TBL] [Abstract][Full Text] [Related]
3. Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.
Castella B; Vitale C; Coscia M; Massaia M
Cell Mol Life Sci; 2011 Jul; 68(14):2419-32. PubMed ID: 21584812
[TBL] [Abstract][Full Text] [Related]
4. Pillars Article: Regulation of Cutaneous Malignancy by γδ T Cells.
Girardi M; Oppenheim DE; Steele CR; Lewis JM; Glusac E; Filler R; Hobby P; Sutton B; Tigelaar RE; Hayday AC
J Immunol; 2018 May; 200(9):3031-3035. PubMed ID: 29685949
[No Abstract] [Full Text] [Related]
5. Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity.
Ferrari de Andrade L; Tay RE; Pan D; Luoma AM; Ito Y; Badrinath S; Tsoucas D; Franz B; May KF; Harvey CJ; Kobold S; Pyrdol JW; Yoon C; Yuan GC; Hodi FS; Dranoff G; Wucherpfennig KW
Science; 2018 Mar; 359(6383):1537-1542. PubMed ID: 29599246
[TBL] [Abstract][Full Text] [Related]
6. Natural killers join the fight against cancer.
Cerwenka A; Lanier LL
Science; 2018 Mar; 359(6383):1460-1461. PubMed ID: 29599226
[No Abstract] [Full Text] [Related]
7. NKG2D: A Master Regulator of Immune Cell Responsiveness.
Wensveen FM; Jelenčić V; Polić B
Front Immunol; 2018; 9():441. PubMed ID: 29568297
[TBL] [Abstract][Full Text] [Related]
8. NKG2D and Its Ligands: "One for All, All for One".
Zingoni A; Molfetta R; Fionda C; Soriani A; Paolini R; Cippitelli M; Cerboni C; Santoni A
Front Immunol; 2018; 9():476. PubMed ID: 29662484
[TBL] [Abstract][Full Text] [Related]
9. The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1s.
Sheppard S; Schuster IS; Andoniou CE; Cocita C; Adejumo T; Kung SKP; Sun JC; Degli-Esposti MA; Guerra N
Cell Rep; 2018 Mar; 22(13):3385-3392. PubMed ID: 29590608
[TBL] [Abstract][Full Text] [Related]
10. A nanoscale reorganization of the IL-15 receptor is triggered by NKG2D in a ligand-dependent manner.
Bálint Š; Lopes FB; Davis DM
Sci Signal; 2018 Apr; 11(525):. PubMed ID: 29636390
[TBL] [Abstract][Full Text] [Related]
11. Celyad's novel CAR T-cell therapy for solid malignancies.
Lonez C; Hendlisz A; Shaza L; Aftimos P; Vouche M; Donckier V; Machiels JH; Van Den Eynde M; Canon JL; Carrasco J; Odunsi K; Sahebjam S; Rottey S; Braun N; Verma B; Gilham DE; Lehmann FF
Curr Res Transl Med; 2018 May; 66(2):53-56. PubMed ID: 29625833
[TBL] [Abstract][Full Text] [Related]
12. Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4.
Zöller T; Wittenbrink M; Hoffmeister M; Steinle A
Front Immunol; 2018; 9():620. PubMed ID: 29651291
[TBL] [Abstract][Full Text] [Related]
13. Intragenic transcriptional interference regulates the human immune ligand MICA.
Lin D; Hiron TK; O'Callaghan CA
EMBO J; 2018 May; 37(10):. PubMed ID: 29643123
[TBL] [Abstract][Full Text] [Related]
14. Antigen-Induced but Not Innate Memory CD8 T Cells Express NKG2D and Are Recruited to the Lung Parenchyma upon Viral Infection.
Grau M; Valsesia S; Mafille J; Djebali S; Tomkowiak M; Mathieu AL; Laubreton D; de Bernard S; Jouve PE; Ventre E; Buffat L; Walzer T; Leverrier Y; Marvel J
J Immunol; 2018 May; 200(10):3635-3646. PubMed ID: 29632146
[TBL] [Abstract][Full Text] [Related]
15. IL-33 attenuates mortality by promoting IFN-γ production in sepsis.
Bao Q; Lv R; Lei M
Inflamm Res; 2018 Jun; 67(6):531-538. PubMed ID: 29610934
[TBL] [Abstract][Full Text] [Related]
16. In Silico Analysis Highlights Potential Predictive Indicators Associated with Secondary Progressive Multiple Sclerosis.
Calabrò M; Lui M; Mazzon E; D'Angiolini S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542346
[TBL] [Abstract][Full Text] [Related]
17. Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient.
Lien SC; Ly D; Yang SYC; Wang BX; Clouthier DL; St Paul M; Gadalla R; Noamani B; Garcia-Batres CR; Boross-Harmer S; Bedard PL; Pugh TJ; Spreafico A; Hirano N; Razak ARA; Ohashi PS
Nat Commun; 2024 Feb; 15(1):1094. PubMed ID: 38321065
[TBL] [Abstract][Full Text] [Related]
18. Killer instincts: natural killer cells as multifactorial cancer immunotherapy.
Nersesian S; Carter EB; Lee SN; Westhaver LP; Boudreau JE
Front Immunol; 2023; 14():1269614. PubMed ID: 38090565
[TBL] [Abstract][Full Text] [Related]
19. γδ T cells: origin and fate, subsets, diseases and immunotherapy.
Hu Y; Hu Q; Li Y; Lu L; Xiang Z; Yin Z; Kabelitz D; Wu Y
Signal Transduct Target Ther; 2023 Nov; 8(1):434. PubMed ID: 37989744
[TBL] [Abstract][Full Text] [Related]
20. Single-cell chromatin accessibility and transcriptomic characterization of Behcet's disease.
Shi W; Ye J; Shi Z; Pan C; Zhang Q; Lin Y; Liang D; Liu Y; Lin X; Zheng Y
Commun Biol; 2023 Oct; 6(1):1048. PubMed ID: 37848613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
